Study Site 32 — Rochester, New York

Study Site 32 is a clinical research site located in Rochester, New York, United States 14618.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 32 has participated in 1 clinical trials.

Therapeutic areas: Chronic Refractory Cough.

Sponsors: Nerre Therapeutics Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 32?

Study Site 32 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 32 conducted?

Study Site 32 has 1 clinical trials on record. Their work covers Chronic Refractory Cough.

Is Study Site 32 accredited by Crixeo Health?

Study Site 32 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 32?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.